{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:39:50Z","timestamp":1761007190089,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.soc.2012.12.004","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T02:02:21Z","timestamp":1356746541000},"page":"345-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multimodality Treatment of\u00a0Pleural Mesothelioma"],"prefix":"10.1016","volume":"22","author":[{"given":"David D.","family":"Shersher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Liptay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2012.12.004_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2012.12.004_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0031-1272874","article-title":"Update on malignant pleura mesothelioma","volume":"32","author":"Campbell","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.soc.2012.12.004_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01243894-200602000-00014","article-title":"Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma","volume":"1","author":"Sugarbaker","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejcts.2006.01.015","article-title":"Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"29","author":"Opitz","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.soc.2012.12.004_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients","volume":"135","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2012.12.004_bib6","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1378\/chest.107.5.1454","article-title":"Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion","volume":"5","author":"Waller","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.soc.2012.12.004_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1010-7940(96)01008-1","article-title":"Pleurectomy\/decortication for palliation in malignant pleural mesothelioma: results of surgery","volume":"11","author":"Soysal","year":"1997","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2012.12.004_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1010-7940(01)00995-2","article-title":"Palliative and surgical debulking in malignant mesothelioma. Predictors of survival and symptom control","volume":"20","author":"Martin-Ucar","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2012.12.004_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejso.2004.08.014","article-title":"Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma","volume":"31","author":"Halstead","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib10","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1183\/09031936.00079407","article-title":"Drain site of radiotherapy in malignant pleural mesothemioma: a wasted resource","volume":"30","author":"Muirhead","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.soc.2012.12.004_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejcts.2007.09.039","article-title":"The role of video assisted thoracoscopic pleurectomy\/decortication in the therapeutic management of malignant pleural mesothelioma","volume":"33","author":"Nakas","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2012.12.004_bib12","first-page":"298","article-title":"Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy","volume":"40","author":"Sugarbaker","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2012.12.004_bib13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"Flores","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib14","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of premtrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib15","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural moesothelioma: an intergroup study for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"Van Meerbeeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Premtrexed plus cisplatin or premtrexed plus carboplatin for chemonaive patients with malignant pleural mesothelioma: results of the International Expanded Access Program","volume":"7","author":"Santoro","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/annonc\/mdm501","article-title":"Phase II study of pemtrexed in combination with carboplatin in patient with malignant pleural mesothelioma (MPM)","volume":"19","author":"Castagneto","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","article-title":"Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma","volume":"24","author":"Ceresoli","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fonc.2011.00022","article-title":"Investigational approaches for mesothelioma","volume":"1","author":"Surmont","year":"2011","journal-title":"Front Oncol"},{"key":"10.1016\/j.soc.2012.12.004_bib20","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1158\/1078-0432.CCR-10-2275","article-title":"Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers","volume":"16","author":"Hassan","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.soc.2012.12.004_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2009.07.016","article-title":"Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: implications for cancer therapy","volume":"68","author":"Hassan","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.soc.2012.12.004_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1200\/JCO.2011.39.6671","article-title":"Serum Mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis","volume":"30","author":"Hollevoet","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.soc.2012.12.004_bib23","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.soc.2012.12.004_bib24","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","article-title":"Markers for the non-invasive diagnosis of mesothelioma: a systematic review","volume":"104","author":"Van der Bij","year":"2011","journal-title":"Br J Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320712001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320712001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:57:46Z","timestamp":1760961466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320712001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1055320712001159"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2012.12.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodality Treatment of\u00a0Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2012.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}